To Redeploy or Dispose of Surplus Assets—That’s the Question

The core business of pharmaceutical companies is geared towards research, manufacturing, sales and marketing.  However, when equipment used for the purpose of research and manufacturing and even assets such as employee computers have reached their useful life, they often times end up sitting idle and taking up space or are disposed of in an inefficient way.  With expense reductions facing many companies in the healthcare and pharmaceutical sector, managers can no longer afford to simply low assets to lie idle or dispose of them without additional thought to the process. Thankfully, there are usable techniques you can start to implement today that will get you on the road to improved utilization of your surplus assets and higher sale or recovery values.